Default: Drug Development Research

ISSN: 0272-4391

Journal Home

Journal Guideline

Drug Development Research Q2 Unclaimed

John Wiley & Sons Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Development Research is a journal indexed in SJR in Drug Discovery with an H index of 70. It has a price of 2950 €. It has an SJR impact factor of 0,756 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,756.

Drug Development Research focuses its scope in these topics and keywords: acetaminophen, heart, dynamic, drug, dppc, diseasesynthesis, diabetic, diabetes, correlation, dysfunction, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Drug Discovery (Q2)
Price

2950 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Drug Development Research

0,756

SJR Impact factor

70

H Index

161

Total Docs (Last Year)

379

Total Docs (3 years)

9794

Total Refs

1561

Total Cites (3 years)

363

Citable Docs (3 years)

4.18

Cites/Doc (2 years)

60.83

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


acetaminophen, heart, dynamic, drug, dppc, diseasesynthesis, diabetic, diabetes, correlation, dysfunction, effect, efficiently, elderlies, failure, function, general, glaucoma, glucosephosphatase, growing, coadministration, classificationidentification, channels, advances, alzheimers, anticancer, antihypoxidoticnootropic, artery, attenuates, aureus, balance, benzimidazole, biomembrane, bisamides, blocks, bone, carotid, cell,

FAQS